Skip to content
SPAC Feed

Curated SPACs News

site-advertisement
  • News
  • Opinions
  • Events
  • Videos
  • Resources
  • Contact Us
1 min to read
  • News
 Posted on April 17, 2023

2022 M&A Review and Outlook – WilmerHale

2022 M&A Review and Outlook  WilmerHale
Source: 2022 M&A Review and Outlook – WilmerHale

  • share 
  • share 
  • share 

Post navigation

10X CAPITAL VENTURE ACQUISITION CORP. II Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K) – Marketscreener.com
Banyan Acquisition Corporation Announces Intent to Adjourn … – Business Wire

Trending Stories

  • Nasdaq Updates Listing Requirements
    Throughout 2024, Nasdaq has been revising the procedures for companies dealing with low stock prices, with a focus on cutting...
  • S-4 – Akari Therapeutics Plc (0001541157) (Filer)
    Filed: 2024-09-13 AccNo: 0001193125-24-218968 Size: 28 MB Source: S-4 - Akari Therapeutics Plc (0001541157) (Filer)
  • Looking Ahead to 2025: Navigating a Shifting D&O Insurance Landscape
    In a market known for volatility, public company D&O (directors & officers) insurance has certainly lived up to its reputation...
  • S-1MEF – Bicara Therapeutics Inc. (0002023658) (Filer)
    Filed: 2024-09-12 AccNo: 0001193125-24-218205 Size: 64 KB Source: S-1MEF - Bicara Therapeutics Inc. (0002023658) (Filer)
  • Private equity-backed SPAC IPOs dwindle – S&P Global
    Private equity-backed SPAC IPOs dwindle  S&P Global Source: Private equity-backed SPAC IPOs dwindle - S&P Global

SPACs Twitter Feed

Twitter feed is not available at the moment.
  • 1
    • S-1 Filing

    S-1 - Spirits Capital Corp (0001881767) (Filer)

  • 2
    • S-1 Filing

    S-1 - Glucotrack, Inc. (0001506983) (Filer)

  • 3
    • News

    Looking Ahead to 2025: Navigating a Shifting D&O Insurance Landscape


SPAC Feed | Subscribe to Newsletter
  • About Us
  • Contact Us
  • Subscribe
Copyright © 2024 SPAC Feed. All Rights Reserved.